Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Social issues Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Health care industry LILLY DRN Healthy Returns
From CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Tags Health care industry Healthy Returns Pfizer Inc
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Tags Health & Science Fulcrum Therapeutics Inc Vertex Pharmaceuticals Inc
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags GSK plc Social issues Health & Science
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Healthy Returns Roche Holding AG Eli Lilly and Co
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Tags Science Health care industry Healthy Returns
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
Tags BioNTech SE Moderna Inc Social issues
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Abbvie Inc Healthy Returns Health & Science
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Zealand Pharma A/S Viking Therapeutics Inc Science
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Health & Science Bristol/Myers Squibb Co Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Biotech and Pharmaceuticals Pfizer Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Biotech and Pharmaceuticals Novo Nordisk A/S UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Oracle Corp
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health care industry Eli Lilly and Co Healthy Returns
From CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
Tags Healthy Returns Alphabet Inc Health care industry
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Biotech and Pharmaceuticals Pfizer Inc Merck & Co Inc
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
Tags Moderna Inc Biotech and Pharmaceuticals Pfizer Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health care industry Science Eli Lilly and Co
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Science Alphabet Inc Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Apple Inc Healthy Returns Health care industry
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Abbvie Inc Healthy Returns CVS Health Corp
From CNBC.com News
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
Tags Alto Neuroscience Inc Biotech and Pharmaceuticals Metagenomi Inc
From CNBC.com News
Healthy Returns: U.S. drug shortages reach record high, hitting Wegovy, ADHD medications
Tags Healthy Returns Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
Tags Healthy Returns Health care industry Science
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.